SDCCQ vs. OSA, OSAP, BLPH, BTTX, SQZ, SIENQ, PTEIQ, ADTX, SXTC, and SCNI
Should you be buying SmileDirectClub stock or one of its competitors? The main competitors of SmileDirectClub include ProSomnus (OSA), ProSomnus (OSAP), Bellerophon Therapeutics (BLPH), Better Therapeutics (BTTX), SQZ Biotechnologies (SQZ), Sientra (SIENQ), PolarityTE (PTEIQ), Aditxt (ADTX), China SXT Pharmaceuticals (SXTC), and Scinai Immunotherapeutics (SCNI). These companies are all part of the "medical" sector.
SmileDirectClub (NASDAQ:SDCCQ) and ProSomnus (NASDAQ:OSA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.
ProSomnus received 4 more outperform votes than SmileDirectClub when rated by MarketBeat users.
ProSomnus has lower revenue, but higher earnings than SmileDirectClub. ProSomnus is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.
ProSomnus has a consensus price target of $2.33, suggesting a potential upside of 5,073.69%. Given ProSomnus' higher probable upside, analysts plainly believe ProSomnus is more favorable than SmileDirectClub.
In the previous week, ProSomnus had 3 more articles in the media than SmileDirectClub. MarketBeat recorded 3 mentions for ProSomnus and 0 mentions for SmileDirectClub. ProSomnus' average media sentiment score of 0.18 beat SmileDirectClub's score of 0.00 indicating that ProSomnus is being referred to more favorably in the news media.
SmileDirectClub has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Comparatively, ProSomnus has a beta of 0.21, suggesting that its share price is 79% less volatile than the S&P 500.
SmileDirectClub has a net margin of 0.00% compared to ProSomnus' net margin of -87.14%.
0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 70.0% of ProSomnus shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 7.7% of ProSomnus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
ProSomnus beats SmileDirectClub on 8 of the 15 factors compared between the two stocks.
Get SmileDirectClub News Delivered to You Automatically
Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SDCCQ vs. The Competition
SmileDirectClub Competitors List
Related Companies and Tools
